BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 28935918)

  • 1. Host-directed therapies for bacterial and viral infections.
    Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
    Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eating the enemy within: autophagy in infectious diseases.
    Orvedahl A; Levine B
    Cell Death Differ; 2009 Jan; 16(1):57-69. PubMed ID: 18772897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance.
    Watson K; Russell CD; Baillie JK; Dhaliwal K; Fitzgerald JR; Mitchell TJ; Simpson AJ; Renshaw SA; Dockrell DH
    Front Immunol; 2020; 11():786. PubMed ID: 32582139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for the development of novel therapies based on host-microbial interactions.
    Santos PC; Teixeira MM; Souza DG
    Pharmacol Res; 2016 Oct; 112():68-83. PubMed ID: 27107789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of host-targeted therapeutics against bacterial infections.
    Varma DM; Zahid MSH; Bachelder EM; Ainslie KM
    Transl Res; 2020 Jun; 220():98-113. PubMed ID: 32268128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimicrobial activity of innate host-directed therapies: A systematic review.
    Shapira T; Christofferson M; Av-Gay Y
    Int J Antimicrob Agents; 2024 May; 63(5):107138. PubMed ID: 38490573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of interleukin-37 in infectious diseases.
    Allam G; Gaber AM; Othman SI; Abdel-Moneim A
    Int Rev Immunol; 2020; 39(1):3-10. PubMed ID: 31633447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of host-directed therapies on the pathology of tuberculosis.
    Tsenova L; Singhal A
    J Pathol; 2020 Apr; 250(5):636-646. PubMed ID: 32108337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-directed therapies for antimicrobial resistant respiratory tract infections.
    Maeurer M; Rao M; Zumla A
    Curr Opin Pulm Med; 2016 May; 22(3):203-11. PubMed ID: 26989822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-Directed Therapeutics as a Novel Approach for Tuberculosis Treatment.
    Kim YR; Yang CS
    J Microbiol Biotechnol; 2017 Sep; 27(9):1549-1558. PubMed ID: 28683527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hijacking the Supplies: Metabolism as a Novel Facet of Virus-Host Interaction.
    Mayer KA; Stöckl J; Zlabinger GJ; Gualdoni GA
    Front Immunol; 2019; 10():1533. PubMed ID: 31333664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host directed therapies: COVID-19 and beyond.
    Tripathi D; Sodani M; Gupta PK; Kulkarni S
    Curr Res Pharmacol Drug Discov; 2021; 2():100058. PubMed ID: 34870156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking the power of the host response to improve the management of infectious diseases.
    Oved K; Eden E; Gottlieb TM
    Future Microbiol; 2019 Oct; 14():1257-1259. PubMed ID: 31849234
    [No Abstract]   [Full Text] [Related]  

  • 14. Host-directed drug targeting of factors hijacked by pathogens.
    Schwegmann A; Brombacher F
    Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Together Forever: Bacterial-Viral Interactions in Infection and Immunity.
    Shi Z; Gewirtz AT
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29534424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections.
    Wilken L; McPherson A
    Int Rev Immunol; 2018 Jan; 37(1):69-76. PubMed ID: 29182399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis.
    du Plessis N; Kotze LA; Leukes V; Walzl G
    Front Cell Infect Microbiol; 2018; 8():332. PubMed ID: 30298121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine therapy of infectious diseases.
    Beaman MH
    Curr Clin Top Infect Dis; 1994; 14():228-51. PubMed ID: 8086118
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibacterial agents--phagocytes: new concepts for old in immunomodulation.
    Labro MT
    Int J Antimicrob Agents; 1998 Apr; 10(1):11-21. PubMed ID: 9624539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines and immunotherapy in infectious diseases].
    van der Meer JW; Netea MG; Kullberg BJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2252-5. PubMed ID: 10578424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.